Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark P. Borman currently holds 526,942 shares of U.S. Stem Cell, Inc. (USRM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark P. Borman has been a net buyer of USRM stock. They have purchased $13.6K and sold $0 worth of shares.
Mark P. Borman's most recent insider trade was on Oct 19, 2018, when they sold 526,918 shares at $0.03 per share.
Mark P. Borman serves as Executive at U.S. Stem Cell, Inc. (USRM). They have executed 2 insider transactions totaling $13.6K over their tenure at the company.
Mark P. Borman holds the position of Executive at U.S. Stem Cell, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
Mark P. Borman has shown a buying trading pattern, with $13.6K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Mark P. Borman was on Oct 19, 2018, when they sold $15.8K worth of USRM shares. This transaction involved 526,918 shares at $0.03 per share.
Mark P. Borman currently owns 526,942 shares of U.S. Stem Cell, Inc. (USRM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark P. Borman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark P. Borman has 2 Form 4 filings on record as an insider at U.S. Stem Cell, Inc..
Set alerts for Mark P. Borman and 40,000+ other insiders.